Tag

Mayo Clinic

All articles tagged with #mayo clinic

health1 day ago

Mayo Clinic Study Links Pre-Treatment Gut Microbes to Cancer Survival and Chemo Side Effects

A large-scale study by Mayo Clinic researchers, published in Cell, identifies distinct gut bacterial signatures in 1,364 cancer patients that correlate with specific cancer types, survival rates, and chemotherapy side effects. The findings suggest that pre-treatment microbiome profiles may predict outcomes, particularly for colorectal and breast cancers in younger adults, and link specific bacteria to diarrhea caused by the drug 5-fluorouracil.

Mayo Clinic Study Links Distinct Gut Microbiome Signatures to Five Cancer Types and Early-Onset Disease
health12 days ago

Mayo Clinic Study Links Distinct Gut Microbiome Signatures to Five Cancer Types and Early-Onset Disease

Mayo Clinic researchers published a study in Cell analyzing stool samples from 1,364 cancer patients, identifying 341 bacterial species linked to five specific cancer groups. The study found distinct microbiome patterns in adults under 50 with colorectal and breast cancer, including higher lactate levels and specific bacteria like Veillonella parvula. Additionally, pre-treatment gut bacteria levels predicted chemotherapy-induced diarrhea, specifically for 5-fluorouracil, offering a potential biomarker for treatment side effects.

Stranger Donor Saves Iowa Father with Stage 4 Cancer
health14 days ago

Stranger Donor Saves Iowa Father with Stage 4 Cancer

Kyler Hess, a father of four from Polk City, Iowa, received a life-saving liver transplant from an unexpected living donor after doctors determined it was the only path to curing his stage 4 colorectal cancer. The donor, Abby Conley, a stranger who followed Hess’s journey online, successfully passed medical tests at the Mayo Clinic in Rochester, Minnesota, after Hess’s brother was deemed ineligible due to anatomical issues. The transplant aims to allow Hess to survive long enough to witness his children’s future milestones.

Mayo Clinic Trial Shows High-Dose Probiotic Reduces Bile Acids in Chronic Diarrhea
health-and-science25 days ago

Mayo Clinic Trial Shows High-Dose Probiotic Reduces Bile Acids in Chronic Diarrhea

A small randomized trial at Mayo Clinic found that a high-dose, eight-strain probiotic reduced fecal primary bile acids in patients with bile acid malabsorption. While the treatment improved biochemical markers and altered gut microbiome composition, it did not significantly change stool consistency or frequency. The authors note the study's small sample size and short duration limit its conclusions, calling for larger, longer trials to confirm therapeutic benefits.

Misdiagnosis to Marathon: How LADA Redefined a Diabetes Battle
health1 month ago

Misdiagnosis to Marathon: How LADA Redefined a Diabetes Battle

Naomi Pineiro, 33, was misdiagnosed with Type 2 diabetes after elevated blood sugar and fatigue, leading to a hospital stay for hyperglycemia. A Mayo Clinic evaluation revealed latent autoimmune diabetes in adults (LADA, or Type 1.5), with very low insulin production. She began insulin therapy and diabetes education, learned to manage glucose with a CGM, and, driven by determination, began running again, completing a Chicago Half Marathon and preparing for the Berlin Marathon as part of her recovery and renewed purpose.

Mayo-quality care for all: an AI-powered blueprint to scale top-tier medicine nationwide
technology1 month ago

Mayo-quality care for all: an AI-powered blueprint to scale top-tier medicine nationwide

An Axios feature argues Mayo Clinic’s AI-powered, team-based care model—where salaries, multidisciplinary collaboration, and real-time data drive patient-centered outcomes—could scale Mayo-quality care across the U.S. The piece notes Mayo’s platform, its partnership with Microsoft, and the need for a national data architecture to unlock AI across hospitals, while acknowledging adoption barriers and policy levers to spur reform.

Carly Simon’s Early Parkinson’s Clues Began as Arthritis
health-news2 months ago

Carly Simon’s Early Parkinson’s Clues Began as Arthritis

Carly Simon revealed she has Parkinson’s disease, whose early signs began with arthritis in her knees and a hip that required joint replacements; after a Mayo Clinic evaluation she was diagnosed, highlighting research showing a link between arthritis (especially osteoarthritis) and Parkinson’s, and noting apathy as a common non-motor symptom; she’s started treatment and continues to work on music, including a new album.

Carly Simon reveals Parkinson's diagnosis, new music on the horizon
entertainment2 months ago

Carly Simon reveals Parkinson's diagnosis, new music on the horizon

Carly Simon says she has Parkinson's disease, diagnosed after a Mayo Clinic evaluation, and that she has also been treated for basal cell carcinoma; she notes the illness is different for everyone and can be unpredictable, with mobility fluctuating day to day. She has begun treatment for stiffness and other symptoms, and says music has helped her cope. The 83-year-old singer is releasing Comes in Waves, her first album of original songs since 2008, on August 14, 2026.

Carly Simon goes public with Parkinson's diagnosis, plans to keep creating music
health2 months ago

Carly Simon goes public with Parkinson's diagnosis, plans to keep creating music

Carly Simon, 81, announced she has Parkinson's disease after years of mobility issues linked to earlier health problems. Diagnosed at the Mayo Clinic and started treatment to manage symptoms; she emphasizes the condition's variability and lack of a cure. Despite health challenges, she remains active creatively, including a new album, Comes in Waves, set for release Aug. 14, and expresses gratitude to family and caregivers.

Mayo Clinic deploys AI to speed exams, organize records, and spot early disease
health2 months ago

Mayo Clinic deploys AI to speed exams, organize records, and spot early disease

Mayo Clinic is rapidly integrating AI into care, with about 150 AI models in use and a record-summarizing tool called Record Time that helps clinicians prepare for patient visits more efficiently. The hospital collaborates with Microsoft and Scale AI to develop healthcare-focused AI and is running clinical pilots (including early pancreatic cancer detection and atrial fibrillation risk analysis) to test accuracy and safety. Mayo emphasizes rigorous validation, clinician involvement, and privacy safeguards, while noting AI will change job roles rather than replace staff, with adoption hinging on trust and practical usefulness.

Couric’s Aspen memory blackout diagnosed as transient global amnesia
health3 months ago

Couric’s Aspen memory blackout diagnosed as transient global amnesia

Journalist Katie Couric experienced a sudden memory lapse at the Aspen Ideas Festival, unable to name the year, president, or panel topics. After medical evaluation ruled out stroke, she was diagnosed with transient global amnesia, a brief, typically reversible episode that can erase recent memories and usually resolves within 24 hours. The exact cause is unknown, though factors like brief disruptions in blood or oxygen flow and other triggers may play a role. Couric recovered and felt back to herself by evening; experts note a recurrence risk exists but episodes are often a one-off event.

technology4 months ago

Mayo Clinic teams with Microsoft to build a specialized frontier AI for medicine

Mayo Clinic and Microsoft are collaborating to develop a frontier AI model tailored for healthcare, combining Mayo’s de-identified clinical data and expertise with Microsoft’s AI and cloud capabilities. The model aims to support earlier diagnoses, personalized treatments, and better patient outcomes, initially tested within Mayo’s clinical environment and later accessible via Azure Foundry APIs, with Mayo owning governance and safety responsibilities.

DNA aptamers pinpoint aging cells, paving the way for targeted treatments
science5 months ago

DNA aptamers pinpoint aging cells, paving the way for targeted treatments

Researchers at Mayo Clinic used DNA aptamers to selectively bind proteins on senescent cells, tagging these 'zombie' cells in mouse tissues and enabling their identification amid healthy cells. The study suggests aptamers could become a cost-effective tool for detecting senescent cells and may eventually enable targeted therapies, though applicability to humans remains to be shown.